Abstract | AIM: METHODS: PKC activity was determined based on the PKC-catalyzed transfer of the (32)P-phosphate group from [g-(32)P] ATP into a PKC-specific peptide substrate. Cell viability was measured by MTT assay. Cell invasion and migration were evaluated by a Boyden chamber assay and scratch wound assay, respectively. Protein expression was analyzed using Western blot assay. The formation of 3-dimensional cellular aggregates was examined by a cell-cell aggregation assay. RESULTS:
UCN-01 treatment resulted in concentration- and time-dependent inhibition of U-87MG cell growth at higher doses (>100 nmol/L), and reduced cell invasion and migration capability at less cytotoxic doses (<100 nmol/L). UCN-01 significantly repressed PKC activity. Consistent with this result, UCN-01 blocked cell invasion stimulated by phorbel 12-myristate-13-acetate (PMA) and ethanol (EtOH), 2 PKC activators. Enforced expression of the tumor suppressor genes BRCA1 and PTEN increased the anti-invasion potential of UCN-01. Exposure to UCN-01 caused a dose-dependent increase in cell adhesion molecule E-cadherin. The effect of UCN-01 on the formation of cell-cell aggregation was significantly reduced by the addition of an anti- E-cadherin antibody. CONCLUSION:
UCN-01 inhibits the invasion and migration of human glioma cells. Accordingly, UCN-01 can have potential clinical applications for the treatment of human glioma metastasis.
|
Authors | Qing-hui Meng, Li-xin Zhou, Jia-lin Luo, Jian-ping Cao, Jian Tong, Sai-jun Fan |
Journal | Acta pharmacologica Sinica
(Acta Pharmacol Sin)
Vol. 26
Issue 4
Pg. 492-9
(Apr 2005)
ISSN: 1671-4083 [Print] United States |
PMID | 15780200
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- BRCA1 Protein
- Cadherins
- RNA, Messenger
- 7-hydroxystaurosporine
- Protein Kinase C
- Staurosporine
|
Topics |
- BRCA1 Protein
(metabolism)
- Cadherins
(biosynthesis, genetics)
- Cell Line, Tumor
- Cell Movement
(drug effects)
- Cell Proliferation
(drug effects)
- Glioblastoma
(enzymology, metabolism, pathology)
- Humans
- Protein Kinase C
(antagonists & inhibitors, metabolism)
- RNA, Messenger
(biosynthesis, genetics)
- Staurosporine
(analogs & derivatives, pharmacology)
|